Federal contractor profile

BIOLIFE SOLUTIONS, INC.

UEI YDDYWUXDERL8CAGE 032Q7

Active
Small Business

Overview

Legal name
BIOLIFE SOLUTIONS, INC.
Registered location
BOTHELL, WA, USA
Primary NAICS
325413 — In-Vitro Diagnostic Substance Manufacturing
Latest award activity
Aug 20, 2026
Read company summary

BIOLIFE SOLUTIONS, INC. is associated with UEI YDDYWUXDERL8 and CAGE 032Q7 in public federal records. AcornBids currently links 5 prime awards totaling $129.3K in obligations to this entity. Its largest recorded federal customer by obligations is Department of Health and Human Services. Its recorded federal awards include work classified as In-Vitro Diagnostic Substance Manufacturing. These categories describe the loaded award records, not a complete list of company capabilities. Its primary SAM.gov NAICS is 325413 (In-Vitro Diagnostic Substance Manufacturing). Its public SAM.gov registration lists BOTHELL, WA, USA.

At a glance

Lifetime prime obligations$129.3K
Prime awards5
Awards with future end dates0
Top-agency concentration100.0%

Prime contract obligations across loaded award records. Obligations are not revenue or contract ceilings. Summary updated Oct 15, 2026. Refresh pending; these totals may be out of date.

Business information

Public SAM.gov registration details.

Legal name
BIOLIFE SOLUTIONS, INC.
UEI
YDDYWUXDERL8
CAGE
032Q7
Registered address
3303 MONTE VILLA PKWY STE 310, BOTHELL, WA, 98021, USA
Registration status
Active
Primary NAICS
325413 — In-Vitro Diagnostic Substance Manufacturing
SAM activation
May 1, 2026
Initial registration
Jul 30, 2021
Entity start
Nov 5, 1987
SAM updated
May 1, 2026
Registration expires
Apr 29, 2027
Fiscal year end
Dec 31
Place of incorporation
DE, USA

View SAM.gov source

Research brief

Source facts

  • Loaded prime-award records link 5 awards and $129,323 in reported obligations to this legal entity. Source
  • Recorded awards include In-Vitro Diagnostic Substance Manufacturing (NAICS 325413); this classification is not proof of every company capability. Source
  • An example award describes: 26-007655 CRYOSTOR CS10, 100 ML BAGS FOR CELL THERAPY MANUFACTURING Source

Federal award analysis

Net transaction obligations by federal fiscal period.

Selected transaction obligations$129.3K
Prime contracts

Reported transaction obligations by federal fiscal period; includes deobligations. Missing transactions are not estimated. Coverage: 5 of 5 selected awards. Select a period to explore its awards.

Funding change

Dated, valued transaction obligations in equal-length adjacent periods; missing records are unknown. Default: last completed federal fiscal year. Percentage is unavailable when the prior period has no positive reported obligations.

MeasureReported value
Current periodOct 1, 2025 – Sep 30, 2026
Current obligations$44.7K
Prior periodOct 1, 2024 – Sep 30, 2025
Prior obligations$84.6K
Change$-39.8K
Growth-47.1%

Where the work is performed

AKMEVTNHWAIDMTNDMNWIMINYMAORNVWYSDIAILINOHPANJCTRICAUTCONEMOKYWVVAMDDEAZNMKSARTNNCSCDCOKLAMSALGAHITXFL

State tile map; darker tiles have larger absolute net obligations. Outlined tiles indicate net deobligations. Unshaded tiles have no reported transactions in this selection. Other locations appear in the table.

Agencies
CategoryPeriod obligationsAwards
Department of Health and Human Services$129.3K5
Offices
CategoryPeriod obligationsAwards
NATIONAL INSTITUTES OF HEALTH - CC$84.6K4
NATIONAL INSTITUTES OF HEALTH OLAO$44.7K1
Naics
CategoryPeriod obligationsAwards
325413 — In-Vitro Diagnostic Substance Manufacturing$129.3K5
Psc
Vehicles
CategoryPeriod obligationsAwards
Unclassified$129.3K5
States
CategoryPeriod obligationsAwards
WA$129.3K5
Set Asides
CategoryPeriod obligationsAwards
NO SET ASIDE USED.$129.3K5

Recent federal awards

Prime contract awards. Select an award to review its history and source evidence.

Award / descriptionAwarding agencyObligationsStart dateEnd date
75N98026P0136326-007655 CRYOSTOR CS10, 100 ML BAGS FOR CELL THERAPY MANUFACTURINGDepartment of Health and Human Services$44.7KAug 19, 2026Sep 18, 2026
75N90025P00614CRYOSTOR CS10 - 100ML BAG BIOLIFE SOLUTIONS, INC.:1168744 [25-007764]Department of Health and Human Services$23.7KAug 6, 2025Sep 5, 2025
75N90025P00557BIOLIFE SOLUTIONS, INC.:1168744 [25-008690] DESCRIPTION:01-CRYOSTOR CS10 - 100ML BAG QTY OF 15 02-CRYOSTOR CS10 - 16ML VIAL QTY OF 25 03-CRYOSTOR CS10 - 10ML VIAL QTY OF 20 POP…Department of Health and Human Services$11.3KJul 2, 2025Jul 31, 2025
75N90025P00223BIOLIFE SOLUTIONS, INC.:1168744 [25-004276] DESCRIPTION: CRYOSTOR CS10 - 100ML BAG PRODUCT NUMBER: 210202 QUANTITY 52 VIALSDepartment of Health and Human Services$24.6KMar 13, 2025Apr 14, 2025
75N90025P00142CRYOSTOR CS10 - 100ML BAGDepartment of Health and Human Services$24.9KDec 24, 2024Apr 1, 2025

Registration, certifications & contacts

Registration evidenceDate
SAM updatedMay 1, 2026
Source loadedSep 26, 2026
Initial registrationJul 30, 2021
Entity startNov 5, 1987

Registration classifications: Small Business. These are separate from the reported certificates above.

IndustryReported size status
325413 — In-Vitro Diagnostic Substance ManufacturingNot reported
333998 — All Other Miscellaneous General Purpose Machinery ManufacturingNot reported
ContactRolePublished contact methodsEvidenceSource date
JENNIFER IEMGovernment businessContact method not publishedSAM registrationNot available
JEN IEMElectronic businessContact method not publishedSAM registrationNot available
Registered industries
  • 325413 — In-Vitro Diagnostic Substance Manufacturing
  • 333998 — All Other Miscellaneous General Purpose Machinery Manufacturing

Registration classifications and published certificates do not by themselves establish eligibility for a particular solicitation. View SAM source

Related companies worth researching

Explore the customer, work and award-size evidence behind each match.

10X GENOMICS, INC.

1 shared agency customer(s); Shared work: 325413 — In-Vitro Diagnostic Substance Manufacturing; Average reported award size within 0.5–2× in matching records. Counts and amounts describe sampled matching awards, not the company’s full history.
46 awards

ULTIMA GENOMICS, INC.

1 shared agency customer(s); Shared work: 325413 — In-Vitro Diagnostic Substance Manufacturing; Average reported award size within 0.5–2× in matching records. Counts and amounts describe sampled matching awards, not the company’s full history.
1 awards

FRANKLIN YOUNG INTERNATIONAL, INCORPORATED

1 shared agency customer(s); Shared work: 325413 — In-Vitro Diagnostic Substance Manufacturing; Average reported award size within 0.5–2× in matching records. Counts and amounts describe sampled matching awards, not the company’s full history.
1 awards

GRIFOLS BIO SUPPLIES INC.

1 shared agency customer(s); Shared work: 325413 — In-Vitro Diagnostic Substance Manufacturing; Average reported award size within 0.5–2× in matching records. Counts and amounts describe sampled matching awards, not the company’s full history.
2 awards

REVVITY HEALTH SCIENCES, INC.

1 shared agency customer(s); Shared work: 325413 — In-Vitro Diagnostic Substance Manufacturing; Average reported award size within 0.5–2× in matching records. Counts and amounts describe sampled matching awards, not the company’s full history.
5 awards

SIEMENS HEALTHCARE DIAGNOSTICS INC.

1 shared agency customer(s); Shared work: 325413 — In-Vitro Diagnostic Substance Manufacturing; Average reported award size within 0.5–2× in matching records. Counts and amounts describe sampled matching awards, not the company’s full history.
2 awards
Data coverage and methodology

Sources: SAM.gov registration, USAspending awards and transactions, and linked supporting records. Prime contract obligations, IDV ceilings and assistance amounts are kept separate. Missing records are not zero activity. Company claims are labeled separately. Recompete signals are rule-based scores out of 100. Positioning windows are AcornBids estimates.

Disclosed relationships only. Missing records do not establish that a contractor has no partners. Ambiguous parent award identifiers are excluded.

Keep your research moving

Save this company, track changes, and evaluate upcoming work against your targets.

Save to my research Find my fit